Citations

Citations to this article as recorded by  

• Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer
  Joo Hye Song, Eun Ran Kim
  The Korean Journal of Internal Medicine.2024; 39(4): 547.     CrossRef
• Small Bowel Capsule Endoscopy within 6 Hours Following Bowel Preparation with Polyethylene Glycol Shows Improved Small Bowel Visibility
  Chang Wan Choi, So Jung Lee, Sung Noh Hong, Eun Ran Kim, Dong Kyung Chang, Young-Ho Kim, Yun Jeong Lim, Ki-Nam Shim, Hyun-Seok Lee
  Diagnostics.2023; 13(3): 469.     CrossRef
• Efficacy of elobixibat as bowel preparation agent for colonoscopy: Prospective, randomized, multi‐center study
  Daisuke Yamaguchi, Hidenori Hidaka, Takuya Matsunaga, Takashi Akutagawa, Yuichiro Tanaka, Amane Jubashi, Yuki Takeuchi, Nanae Tsuruoka, Yasuhisa Sakata, Koichi Miyahara, Naoyuki Tominaga, Hiroharu Kawakubo, Ayako Takamori, Ryo Shimoda, Takahiro Noda, Shin
  Digestive Endoscopy.2022; 34(1): 171.     CrossRef
• Postgastrectomy gastric cancer patients are at high risk for colorectal neoplasia: a case control study
  Tae-Geun Gweon, Kyu-Tae Yoon, Chang Hyun Kim, Jin-Jo Kim
  Intestinal Research.2021; 19(2): 239.     CrossRef
• How to Choose the Optimal Bowel Preparation Regimen for Colonoscopy
  Ji Eun Na, Eun Ran Kim
  The Ewha Medical Journal.2021; 44(4): 122.     CrossRef
• Comparison of bowel-cleansing efficacy of split-dose and same-day dose bowel preparation for afternoon colonoscopy in patients with gastrectomy: a prospective randomized study
  Tae-Geun Gweon, Cheal Wung Huh, Jeong Seon Ji, Chang Hyun Kim, Jin-Jo Kim, Seung-Man Park
  Surgical Endoscopy.2020; 34(10): 4413.     CrossRef
• Efficacy of 1.2 L polyethylene glycol plus ascorbic acid for bowel preparations
  Hiroyuki Tamaki, Teruyo Noda, Masahiro Morita, Akina Omura, Atsushi Kubo, Chikara Ogawa, Toshihiro Matsunaka, Mitsushige Shibatoge
  World Journal of Clinical Cases.2019; 7(4): 452.     CrossRef
• Comparison of Bowel Cleansing Efficacy, Safety, Bowel Movement Kinetics, and Patient Tolerability of Same-Day and Split-Dose Bowel Preparation Using 4 L of Polyethylene Glycol: A Prospective Randomized Study
  Myeongsook Seo, Tae-Geun Gweon, Cheal Wung Huh, Jeong Seon Ji, Hwang Choi
  Diseases of the Colon & Rectum.2019; 62(12): 1518.     CrossRef
• Can water insufflation and carbon dioxide overcome the difficulties of colonoscope insertion?
  Choong-Kyun Noh, Kee Myung Lee
  Intestinal Research.2018; 16(2): 166.     CrossRef
• Comparable Efficacy of a 1-L PEG and Ascorbic Acid Solution Administered with Bisacodyl versus a 2-L PEG and Ascorbic Acid Solution for Colonoscopy Preparation: A Prospective, Randomized and Investigator-Blinded Trial
  Ji Eun Kwon, Jung Won Lee, Jong Pil Im, Ji Won Kim, Su Hwan Kim, Seong-Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Sang Gyun Kim, Joo Sung Kim, Hyun Chae Jung, John Green
  PLOS ONE.2016; 11(9): e0162051.     CrossRef
• Low Volume Polyethylene Glycol (PEG) Plus Ascorbic Acid, a Valid Alternative to Standard PEG
  Su Hwan Kim, Ji Won Kim
  Gut and Liver.2016; 10(2): 160.     CrossRef
• Does Polyethylene Glycol (PEG) Plus Ascorbic Acid Induce More Mucosal Injuries than Split-Dose 4-L PEG during Bowel Preparation?
  Min Sung Kim, Jongha Park, Jae hyun Park, Hyung Jun Kim, Hyun Jeong Jang, Hee Rin Joo, Ji Yeon Kim, Joon Hyuk Choi, Nae Yun Heo, Seung Ha Park, Tae Oh Kim, Sung Yeon Yang
  Gut and Liver.2016; 10(2): 237.     CrossRef

Citations

Citations to this article as recorded by  

• Can narrow-band imaging of Peyer's patches predict the recurrence of ulcerative colitis?
  Yoon Jae Kim
  Intestinal Research.2016; 14(4): 295.     CrossRef
• Effectiveness of a Turbo Direction Change for Reduction of Motion Artifact in Magnetic Resonance Enterography
  Kwan-Woo Choi, Soon-Yong Son, Mi-Ae Jeong
  Journal of Magnetics.2016; 21(3): 421.     CrossRef

Human cytomegalovirus (HCMV) is a member of the herpesvirus family. HCMV infection persists throughout the host lifespan in a latent state following primary infection. The ability of HCMV to escape control by the host immune system and its resulting reactivation suggests the importance of ongoing immune surveillance in the prevention of HCMV reactivation. HCMV is a common cause of opportunistic infection that causes severe and fatal disease in immune-compromised individuals. In inflammatory bowel disease patients, particularly those with ulcerative colitis (UC), HCMV is often reactivated because these patients are frequently treated with immunosuppressive agents. This reactivation exacerbates colitis. Additionally, HCMV infection can induce severe colitis, even in patients with UC who have never been treated with immunosuppressive agents. However, the role of HCMV in colonic inflammation in patients with UC remains unclear. Here, we present previous and current clinical data on the diagnosis and treatment of HCMV infection in UC. Additionally, our experimental data from a newly established mouse model mimicking UC with concomitant CMV infection clearly demonstrate that inflammation could result in the exacerbation of UC disease activity with induction of HCMV reactivation. In summary, optimal control of colonic inflammation should be achieved in UC patients who are refractory to conventional immunosuppressive therapies and are positive for HCMV.

Citations

Citations to this article as recorded by  

• Impact of cytomegalovirus on outcomes in acute severe ulcerative colitis: a retrospective observational study
  Dazhong Huang, Michael Rennie, Alicia Krasovec, Shyam Nagubandi, Sichang Liu, Edward Ge, Barinder Khehra, Michael Au, Shobini Sivagnanam, Vu Kwan, Claudia Rogge, Nikola Mitrev, Viraj Kariyawasam
  Therapeutic Advances in Chronic Disease.2024;[Epub]     CrossRef
• Cytomegalovirus in Ulcerative Colitis: An Unwanted “Guest”
  Danusia Onisor, Olga Brusnic, Simona Mocan, Mircea Stoian, Calin Avram, Adrian Boicean, Daniela Dobru
  Pathogens.2024; 13(8): 650.     CrossRef
• The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection
  Tsukasa Yamawaka, Hiroki Kitamoto, Masanori Nojima, Tomoe Kazama, Kohei Wagatsuma, Keisuke Ishigami, Shuji Yamamoto, Yusuke Honzawa, Minoru Matsuura, Hiroshi Seno, Hiroshi Nakase
  Journal of Gastroenterology.2023; 58(1): 44.     CrossRef
• Microscopic observations of sites and forms of ettringite in the microstructure of deteriorated concrete
  Y. Ando, H. Shinichi, T. Katayama, K. Torii
  Materiales de Construcción.2022; 72(346): e283.     CrossRef
• Ulcerative Colitis and Its Association with Cytomegalovirus
  梦鸽 李
  Advances in Clinical Medicine.2022; 12(06): 5506.     CrossRef
• Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study
  Hong Yang, Zhihua Ran, Meng Jin, Jia-Ming Qian
  Gut and Liver.2022; 16(5): 726.     CrossRef
• Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation
  Alexandre Jentzer, Sébastien Fauteux-Daniel, Paul Verhoeven, Aymeric Cantais, Melyssa Yaugel Novoa, Fabienne Jospin, Blandine Chanut, Nicolas Rochereau, Thomas Bourlet, Xavier Roblin, Bruno Pozzetto, Sylvie Pillet
  Viruses.2022; 14(12): 2595.     CrossRef
• Human Cytomegalovirus and Autoimmune Diseases: Where Are We?
  Francesca Gugliesi, Selina Pasquero, Gloria Griffante, Sara Scutera, Camilla Albano, Sergio Fernando Castillo Pacheco, Giuseppe Riva, Valentina Dell’Oste, Matteo Biolatti
  Viruses.2021; 13(2): 260.     CrossRef
• Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission
  Jongbeom Shin, Sung Min Kong, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim
  Gut and Liver.2021; 15(3): 401.     CrossRef
• Clinical characteristics of cytomegalovirus gastritis
  Dan Chen, Ruijie Zhao, Wei Cao, Weixun Zhou, Ying Jiang, Shangzhu Zhang, Yang Chen, Guijun Fei, Ji Li, Jiaming Qian
  Medicine.2020; 99(5): e18927.     CrossRef
• Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data
  Yoshihiro Yokoyama, Tsukasa Yamakawa, Takehiro Hirano, Tomoe Kazama, Daisuke Hirayama, Kohei Wagatsuma, Hiroshi Nakase
  International Journal of Molecular Sciences.2020; 21(7): 2438.     CrossRef
• Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
  Alexandre Jentzer, Pauline Veyrard, Xavier Roblin, Pierre Saint-Sardos, Nicolas Rochereau, Stéphane Paul, Thomas Bourlet, Bruno Pozzetto, Sylvie Pillet
  Microorganisms.2020; 8(7): 1078.     CrossRef
• Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
  Yoki Furuta, Hideaki Miyamoto, Hideaki Naoe, Miki Shimoda, Yukari Hinokuma, Tomohiro Miyamura, Azusa Miyashita, Satoshi Fukushima, Motohiko Tanaka, Yutaka Sasaki
  Case Reports in Gastroenterology.2020; 14(1): 103.     CrossRef
• Exacerbation causes among inflammatory bowel disease patients in Guilan Province north of Iran
  Raheleh Sadat Hosseini, Fariborz Mansour-Ghanaei, Afshin Shafaghi, Amineh Hojati, Farahnaz Joukar, Zahra Atrkar Roushan, Fakhri Alsadat Hosseini, Sara Mavaddati
  Journal of Coloproctology.2019; 39(02): 138.     CrossRef
• Management of elderly ulcerative colitis in Japan
  Masaaki Higashiyama, Akira Sugita, Kazutaka Koganei, Kenji Wanatabe, Yoko Yokoyama, Motoi Uchino, Masakazu Nagahori, Makoto Naganuma, Shigeki Bamba, Shingo Kato, Ken Takeuchi, Teppei Omori, Tomohisa Takagi, Satohiro Matsumoto, Mitsuo Nagasaka, Shintaro Sa
  Journal of Gastroenterology.2019; 54(7): 571.     CrossRef
• Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)
  
  Intestinal Research.2018; 16(2): 178.     CrossRef
• Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants
  Yujiro Henmi, Kazuki Kakimoto, Takuya Inoue, Kei Nakazawa, Minori Kubota, Azusa Hara, Takashi Mikami, Yutaka Naka, Yuki Hirata, Yoshimasa Hirata, Taisuke Sakanaka, Sadaharu Nouda, Toshihiko Okada, Ken Kawakami, Toshihisa Takeuchi, Kazunari Tominaga, Kazuh
  Journal of Clinical Biochemistry and Nutrition.2018; 63(3): 246.     CrossRef
• Treatment of inflammatory bowel disease by leukocytapheresis
  Emre Gerçeker, Hakan Yüceyar, Elmas Kasap, Ufuk Demirci, Burcu Ceren Ekti, İsmet Aydoğdu, Mine Miskioğlu
  Transfusion and Apheresis Science.2017; 56(3): 421.     CrossRef
• Targeting cytomegalovirus during ulcerative colitis flare-ups
  Hiroshi Nakase, Kei Onodera
  Expert Review of Gastroenterology & Hepatology.2016; 10(10): 1119.     CrossRef
• Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease Registry
  Hai Yun Shi, Francis K. L. Chan, Wai Keung Leung, Michael K. K. Li, Chi Man Leung, Shun Fung Sze, Jessica Y. L. Ching, Fu Hang Lo, Steve W. C. Tsang, Edwin H. S. Shan, Lai Yee Mak, Belsy C. Y. Lam, Aric J. Hui, Sai Ho Wong, Marc T. L. Wong, Ivan F. N. Hun
  Journal of Crohn's and Colitis.2016; 10(2): 176.     CrossRef
• Cytomegalovirus in inflammatory bowel disease: A systematic review
  Tessa EH Römkens
  World Journal of Gastroenterology.2016; 22(3): 1321.     CrossRef
• Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2ndAsian Organization of Crohn's and Colitis (AOCC) meeting in Seoul
  Hiroshi Nakase, Bora Keum, Byoung Duk Ye, Soo Jung Park, Hoon Sup Koo, Chang Soo Eun
  Intestinal Research.2016; 14(3): 231.     CrossRef
• Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis
  Ho-Su Lee, Sang Hyoung Park, Sung-Han Kim, Jihun Kim, Jene Choi, Hyo Jeong Lee, Wan Soo Kim, Jeong-Mi Lee, Min Seob Kwak, Sung Wook Hwang, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Ki
  Inflammatory Bowel Diseases.2016; 22(4): 912.     CrossRef
• Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells
  Raymond H. de Wit, Azra Mujić-Delić, Jeffrey R. van Senten, Alberto Fraile-Ramos, Marco Siderius, Martine J. Smit
  Oncotarget.2016; 7(42): 67966.     CrossRef
• Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences
  Hiroshi Nakase, Hans Herfarth
  Inflammatory Intestinal Diseases.2016; 1(1): 15.     CrossRef
• Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis
  Sylvie Pillet, Camille Jarlot, Mathilde Courault, Emilie Del Tedesco, Renaud Chardon, Pierre Saint-Sardos, Emilie Presles, Jean-Marc Phelip, Philippe Berthelot, Bruno Pozzetto, Xavier Roblin
  Inflammatory Bowel Diseases.2015; 21(7): 1580.     CrossRef
• Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis
  Saifun Nahar
  World Journal of Gastroenterology.2015; 21(44): 12667.     CrossRef
• Author's Reply
  Jaeyoung Chun, Jong Pil Im
  Intestinal Research.2015; 13(2): 184.     CrossRef
• Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation
  You Sun Kim, Joo Sung Kim
  Gut and Liver.2015; 9(2): 254.     CrossRef
• Usefulness of the Cytomegalovirus Antigenemia Assay in Patients With Ulcerative Colitis
  Jaeyoung Chun, Changhyun Lee, Ji-eun Kwon, Sung Wook Hwang, Sang Gyun Kim, Joo Sung Kim, Hyun Chae Jung, Jong Pil Im
  Intestinal Research.2015; 13(1): 50.     CrossRef
• Long-Term Outcomes of Cytomegalovirus Reactivation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Study
  You Sun Kim, Young-Ho Kim, Joo Sung Kim, Seong Yeon Jeong, Soo Jeong Park, Jae Hee Cheon, Byong Duk Ye, Sung-Ae Jung, Young Sook Park, Chang Hwan Choi, Kyeung Ok Kim, Byung Ik Jang, Dong Soo Han, Suk-Kyun Yang, Won Ho Kim
  Gut and Liver.2014; 8(6): 643.     CrossRef

Patients with intractable inflammatory bowel diseases (IBD) are increasingly being treated with anti-tumor necrosis factor (TNF) agents and are at increased risk of developing tuberculosis (TB). Therefore, diagnosis and treatment of latent TB infection (LTBI) is recommended in patients due to the initiation of anti-TNF therapy. Traditionally, LTBI has been diagnosed on the basis of clinical factors and a tuberculin skin test. Recently, interferon-gamma releasing assays (IGRAs) that can detect TB infection have become available. Considering the high-risk of developing TB in patients on anti-TNF therapy, the use of both a tuberculin skin test and an IGRA should be considered to detect and treat LTBI in patients with IBD due to the initiation of anti-TNF therapy. The traditional LTBI treatment regimen has consisted of isoniazid monotherapy for 9 months. However, shorter regimens such as 4 months of rifampicin or 3 months of isoniazid/rifampicin have been used increasingly to improve treatment completion rates. In this review, the incidence of TB and the prevalence of LTBI in patients with IBD will be briefly described, as well as methods for diagnosing latent and active TB before anti-TNF therapy, current LTBI treatment regimens, recommendations for managing TB that develops during anti-TNF therapy, the necessity of regular monitoring to detect new TB infection, and the re-initiation of anti-TNF therapy in patients who develop TB.

Citations

Citations to this article as recorded by  

• Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening
  Suprabhat Giri, Sukanya Bhrugumalla, Akash Shukla, Sagar Gangadhar, Srujan Reddy, Sumaswi Angadi, Leela Shinde, Aditya Kale
  Arab Journal of Gastroenterology.2024;[Epub]     CrossRef
• Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures
  Rim Lakhmiri, Yahia Cherrah, Samira Serragui
  Current Drug Safety.2024; 19(4): 431.     CrossRef
• Screening of latent tuberculosis infection among patients with diabetes mellitus from a high-burden area in Brazil
  Amanda Vital Torres, Raquel da Silva Corrêa, Maria de Fátima Bevilacqua, Luana Cristina França do Prado, Flavia Miranda Gomes de Constantino Bandeira, Luciana Silva Rodrigues, Marilia Brito Gomes
  Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
• Comparison of Interferon-Gamma Release Assay and Tuberculin Skin Test for the Screening of Latent Tuberculosis in Inflammatory Bowel Disease Patients: Indian Scenario
  Alok Kumar Mantri, Priti Meena, Amarender Singh Puri, Ajay Kumar, Sanjeev Sachdeva, Siddharth Srivastava, K. Arivarasan, Shivakumar Varakanahali, Jos R. Lapa e Silva
  Tuberculosis Research and Treatment.2021; 2021: 1.     CrossRef
• Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
  Jae Yong Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Ho-Su Lee, Kyung-Wook Jo, Sang Hyoung Park
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Risk stratification and management of QuantiFERON-positive solid-organ living donors
  Jean Gibb, Darren Wong
  Current Opinion in Organ Transplantation.2020; 25(4): 351.     CrossRef
• Variations of tuberculin skin test in patients with rheumatologic disorders and under anti-TNF treatment
  Tayfun Özdemir, Serpil Tuna, Özlem Karataş, Mehmet İhsan Arman
  Journal of Surgery and Medicine.2019;[Epub]     CrossRef
• Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 1: Risk assessment
  Dong II Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Journal of Gastroenterology and Hepatology.2018; 33(1): 20.     CrossRef
• A Surprising Granulomatous Cheilitis
  Chloé Charpentier, Diane Kottler, Charlotte Fite, Anne-Laure Pelletier, Lydia Deschamps, Vincent Descamps
  Gastroenterology.2018; 154(5): 1239.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Intestinal Research.2018; 16(1): 17.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti‐tumor necrosis factor treatment. Part 2: Management
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin‐Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Journal of Gastroenterology and Hepatology.2018; 33(1): 30.     CrossRef
• Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
  Dong Il Park, Tadakazu Hisamatsu, Minhu Chen, Siew Chien Ng, Choon Jin Ooi, Shu Chen Wei, Rupa Banerjee, Ida Normiha Hilmi, Yoon Tae Jeen, Dong Soo Han, Hyo Jong Kim, Zhihua Ran, Kaichun Wu, Jiaming Qian, Pin-Jin Hu, Katsuyoshi Matsuoka, Akira Andoh, Yasu
  Intestinal Research.2018; 16(1): 4.     CrossRef
• Second Korean guidelines for the management of ulcerative colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  Intestinal Research.2017; 15(1): 7.     CrossRef
• Second Korean Guideline for the Management of Ulcerative Colitis
  Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han
  The Korean Journal of Gastroenterology.2017; 69(1): 1.     CrossRef
• Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease
  Shi-xue Dai, Hong-xiang Gu, Qian-yi Lin, Yan-kun Wu, Xiao-yan Wang, Shao-zhuo Huang, Tiao-si Xing, Min-hua Chen, Qing-fang Zhang, Zhong-wen Zheng, Wei-hong Sha
  Medicine.2017; 96(26): e7247.     CrossRef
• Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
  Cândida Abreu, Joana Afonso, Cláudia Camila Dias, Rogério Ruas, António Sarmento, Fernando Magro
  Journal of Crohn's and Colitis.2017; 11(10): 1223.     CrossRef
• Association between TNF -308G/A polymorphism and susceptibility to pulmonary tuberculosis in the Lur population of Iran
  Farhad Shahsavar, Ali Mohammad Varzi, Alireza Azargoon
  Asian Pacific Journal of Tropical Biomedicine.2016; 6(1): 80.     CrossRef
• Differences in Clinical Manifestations according to the Positivity of Interferon-γ Assay in Patients with Intestinal Tuberculosis
  Hye Jin Jung, Young-Ho Kim, You Sun Kim, Seong Yeon Jeong, Sung Won Park, Ji Yeon Seo, Hyemi Jung, Jong Pil Im, Ji Won Kim, Sung Noh Hong, Kuk Lae Lee
  Gut and Liver.2016; 10(4): 649.     CrossRef
• Reactivation tuberculosis: role of surveillance
  Andrew R. DiNardo, Elizabeth Guy
  Expert Review of Anti-infective Therapy.2016; 14(5): 501.     CrossRef
• Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis
  Jatinderpal Singh, Amarender S Puri, Sanjeev Sachdeva, Puja Sakhuja, Kulandaivelu Arivarasan
  Intestinal Research.2016; 14(2): 183.     CrossRef
• Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
  Jang Wook Lee, Chang Hwan Choi, Ji Hoon Park, Jeong Wook Kim, Sang Bum Kang, Ja Seol Koo, Young-Ho Kim, You Sun Kim, Young Eun Joo, Sae Kyung Chang
  Intestinal Research.2016; 14(2): 146.     CrossRef
• How Should We Manage Latent Tuberculosis Infection in Patients Receiving Anti-TNF-α Drugs: Literature Review
  Hamid Reza Naderi, Fereshte Sheybani, Susan Rezaei Pajand
  Iranian Red Crescent Medical Journal.2016;[Epub]     CrossRef
• Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
  Chang Hwan Choi, In Do Song, Young-Ho Kim, Ja Seol Koo, You Sun Kim, Joo Sung Kim, Nayoung Kim, Eun Soo Kim, Jae Hak Kim, Ji Won Kim, Tae Oh Kim, Hyun Soo Kim, Hyo Jong Kim, Young Sook Park, Dong Il Park, Soo Jung Park, Hyun Joo Song, Sung Jae Shin, Suk-K
  Yonsei Medical Journal.2016; 57(6): 1376.     CrossRef
• Infektiöse Komplikationen der immunsuppressiven Therapie
  T. Feldkamp, O. Witzke
  Der Nephrologe.2015; 10(1): 38.     CrossRef
• Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
  Jung Won Lee, Jong Pil Im, Jae Hee Cheon, You Sun Kim, Joo Sung Kim, Dong Soo Han
  Intestinal Research.2015; 13(3): 213.     CrossRef
• Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
  Bruno Rafael Ramos de Mattos, Maellin Pereira Gracindo Garcia, Julia Bier Nogueira, Lisiery Negrini Paiatto, Cassia Galdino Albuquerque, Caique Lopes Souza, Luís Gustavo Romani Fernandes, Wirla Maria da Silva Cunha Tamashiro, Patricia Ucelli Simioni, Even
  Mediators of Inflammation.2015;[Epub]     CrossRef
• Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy
  Tae Sun Shim
  Tuberculosis and Respiratory Diseases.2014; 76(6): 261.     CrossRef

Mucosal surface of the intestinal tract is continuously exposed to a large number of microorganisms. To manage the substantial microbial exposure, epithelial surfaces produce a diverse arsenal of antimicrobial proteins (AMPs) that directly kill or inhibit the growth of microorganisms. Thus, AMPs are important components of innate immunity in the gut mucosa. They are frequently expressed in response to colonic inflammation and infection. Expression of many AMPs, including human β-defensin 2-4 and cathelicidin, is induced in response to invasion of pathogens or enteric microbiota into the mucosal barrier. In contrast, some AMPs, including human α-defensin 5-6 and human β-defensin 1, are constitutively expressed without microbial contact or invasion. In addition, specific AMPs are reported to be associated with inflammatory bowel disease (IBD) due to altered expression of AMPs or development of autoantibodies against AMPs. The advanced knowledge for AMPs expression in IBD can lead to its potential use as biomarkers for disease activity. Although the administration of exogenous AMPs as therapeutic strategies against IBD is still at an early stage of development, augmented induction of endogenous AMPs may be another interesting future research direction for the protective and therapeutic purposes. This review discusses new advances in our understanding of how intestinal AMPs protect against pathogens and contribute to pathophysiology of IBD.

Citations

Citations to this article as recorded by  

• Intestinal Epithelial Axin1 Deficiency Protects Against Colitis via Altered Gut Microbiota
  Shari Garrett, Yongguo Zhang, Yinglin Xia, Jun Sun
  Engineering.2024; 35: 241.     CrossRef
• Evaluation of potential antiviral activities of antimicrobial peptides in fish mucus
  Irmak Dik, Burak Dik, Öznur Tufan, Ayşe Er
  Fundamental & Clinical Pharmacology.2024; 38(4): 695.     CrossRef
• A COMBINATION REVIEW ON EFFECT OF CITRUS JUICE AND METRONIDAZOLE IN INFLAMMATORY BOWEL DISEASE
  Deeksha, Shalini Saini, Meenakshi Bhatt
  International Journal of Research -GRANTHAALAYAH.2023;[Epub]     CrossRef
• Oral Delivery of Mouse β-Defensin 14 (mBD14)-Producing Lactococcus lactis NZ9000 Attenuates Experimental Colitis in Mice
  Haizhi Tian, Jiahong Li, Xiaopei Chen, Zhengnan Ren, Xiaohua Pan, Weining Huang, Madhav Bhatia, Li-Long Pan, Jia Sun
  Journal of Agricultural and Food Chemistry.2023; 71(13): 5185.     CrossRef
• Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota
  Zarwa Saqib, Giada De Palma, Jun Lu, Michael Surette, Premysl Bercik, Stephen Michael Collins
  Gut Microbes.2023;[Epub]     CrossRef
• COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy
  Yogesh Kumar Verma, Ranjan Verma, Nishant Tyagi, Amanpreet Behl, Subodh Kumar, Gurudutta U. Gangenahalli
  Stem Cell Reviews and Reports.2021; 17(1): 113.     CrossRef
• Cathelicidin – A Novel Potential Marker of Pediatric Inflammatory Bowel Disease
  Paulina Krawiec, Elżbieta Pac-Kożuchowska
  Journal of Inflammation Research.2021; Volume 14: 163.     CrossRef
• Protective effects of potential probiotic Lactobacillus rhamnosus (MTCC-5897) fermented whey on reinforcement of intestinal epithelial barrier function in a colitis-induced murine model
  Harpreet Kaur, Taruna Gupta, Suman Kapila, Rajeev Kapila
  Food & Function.2021; 12(13): 6102.     CrossRef
• Human β-Defensin 2 and Its Postulated Role in Modulation of the Immune Response
  Martyna Cieślik, Natalia Bagińska, Andrzej Górski, Ewa Jończyk-Matysiak
  Cells.2021; 10(11): 2991.     CrossRef
• Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases
  Johanna Born, Alexander Hendricks, Charlotte Hauser, Jan-Hendrik Egberts, Thomas Becker, Christian Röder, Susanne Sebens
  Cancers.2021; 14(1): 47.     CrossRef
• Mucosal expression of defensin-5, soluble phospholipase A2 and lysozyme in the intestine in a rat model of acute liver failure and its relationship to intestinal bacterial translocation
  Silin Chen, Xiaopeng Li, Ming Li, Qing Mei, Juanjun Huang, Zhenping Wu, Lunli Zhang
  Gastroenterología y Hepatología.2020; 43(6): 293.     CrossRef
• High circulating elafin levels are associated with Crohn’s disease-associated intestinal strictures
  Jiani Wang, Christina Ortiz, Lindsey Fontenot, Ying Xie, Wendy Ho, S. Anjani Mattai, David Q. Shih, Hon Wai Koon, Pal Bela Szecsi
  PLOS ONE.2020; 15(4): e0231796.     CrossRef
• Toxicomicrobiomics: The Human Microbiome vs. Pharmaceutical, Dietary, and Environmental Xenobiotics
  Nehal Adel Abdelsalam, Ahmed Tarek Ramadan, Marwa Tarek ElRakaiby, Ramy Karam Aziz
  Frontiers in Pharmacology.2020;[Epub]     CrossRef
• Mucosal expression of defensin-5, soluble phospholipase A2 and lysozyme in the intestine in a rat model of acute liver failure and its relationship to intestinal bacterial translocation
  Silin Chen, Xiaopeng Li, Ming Li, Qing Mei, Juanjun Huang, Zhenping Wu, Lunli Zhang
  Gastroenterología y Hepatología (English Edition).2020; 43(6): 293.     CrossRef
• Mesenchymal Stromal Cells as Potential Antimicrobial for Veterinary Use—A Comprehensive Review
  Keith A. Russell, Livia C. Garbin, Jonathan M. Wong, Thomas G. Koch
  Frontiers in Microbiology.2020;[Epub]     CrossRef
• Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice
  Seong-Joon Koh, Youn-I Choi, Yuri Kim, Yoo-Sun Kim, Sang Woon Choi, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee
  European Journal of Nutrition.2019; 58(4): 1603.     CrossRef
• Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk
  Ajaz A. Bhat, Srijayaprakash Uppada, Iman W. Achkar, Sheema Hashem, Santosh K. Yadav, Muralitharan Shanmugakonar, Hamda A. Al-Naemi, Mohammad Haris, Shahab Uddin
  Frontiers in Physiology.2019;[Epub]     CrossRef
• Gene and Mirna Regulatory Networks During Different Stages of Crohn’s Disease
  Sare Verstockt, Gert De Hertogh, Jan Van der Goten, Bram Verstockt, Maaike Vancamelbeke, Kathleen Machiels, Leentje Van Lommel, Frans Schuit, Gert Van Assche, Paul Rutgeerts, Marc Ferrante, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen
  Journal of Crohn's and Colitis.2019; 13(7): 916.     CrossRef
• Impact of the Food Additive Titanium Dioxide (E171) on Gut Microbiota-Host Interaction
  Gabriela Pinget, Jian Tan, Bartlomiej Janac, Nadeem O. Kaakoush, Alexandra Sophie Angelatos, John O'Sullivan, Yen Chin Koay, Frederic Sierro, Joel Davis, Shiva Kamini Divakarla, Dipesh Khanal, Robert J. Moore, Dragana Stanley, Wojciech Chrzanowski, Lauren
  Frontiers in Nutrition.2019;[Epub]     CrossRef
• Duodenal expression of antimicrobial peptides in dogs with idiopathic inflammatory bowel disease and intestinal lymphoma
  M. Nakazawa, S. Maeda, M. Omori, K. Kaji, N. Yokoyama, T. Nakagawa, J.K. Chambers, K. Uchida, K. Ohno, T. Yonezawa, N. Matsuki
  The Veterinary Journal.2019; 249: 47.     CrossRef
• Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies
  Liang Jin, Li Li, Chenqi Hu, Jesus Paez-Cortez, Yingtao Bi, Michael Macoritto, Sherry Cao, Yu Tian
  Inflammatory Bowel Diseases.2019; 25(12): 1906.     CrossRef
• Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells
  Reza Esfandiyari, Raheleh Halabian, Elham Behzadi, Hamid Sedighian, Ramezan Jafari, Abbas Ali Imani Fooladi
  Heliyon.2019; 5(10): e02652.     CrossRef
• Intestinal barrier integrity and inflammatory bowel disease: Stem cell‐based approaches to regenerate the barrier
  Fredrik E.O. Holmberg, Jannie Pedersen, Peter Jørgensen, Christoffer Soendergaard, Kim B. Jensen, Ole H. Nielsen
  Journal of Tissue Engineering and Regenerative Medicine.2018; 12(4): 923.     CrossRef
• Growth characteristics of Chlamydia trachomatis in human intestinal epithelial Caco-2 cells
  Ildikó Lantos, Dezső P Virok, Tímea Mosolygó, Zsolt Rázga, Katalin Burián, Valéria Endrész
  Pathogens and Disease.2018;[Epub]     CrossRef
• The DH31/CGRP enteroendocrine peptide triggers intestinal contractions favoring the elimination of opportunistic bacteria
  Olivia Benguettat, Rouba Jneid, Julie Soltys, Rihab Loudhaief, Alexandra Brun-Barale, Dani Osman, Armel Gallet, Karel Talavera
  PLOS Pathogens.2018; 14(9): e1007279.     CrossRef
• P17, an Original Host Defense Peptide from Ant Venom, Promotes Antifungal Activities of Macrophages through the Induction of C-Type Lectin Receptors Dependent on LTB4-Mediated PPARγ Activation
  Khaddouj Benmoussa, Hélène Authier, Mélissa Prat, Mohammad AlaEddine, Lise Lefèvre, Mouna Chirine Rahabi, José Bernad, Agnès Aubouy, Elsa Bonnafé, Jérome Leprince, Bernard Pipy, Michel Treilhou, Agnès Coste
  Frontiers in Immunology.2017;[Epub]     CrossRef
• Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA
  Maureen C. Turina, Robert Landewé, Dominique Baeten
  Expert Review of Clinical Immunology.2017; 13(4): 333.     CrossRef
• Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia
  Junbae Jee, Reena Mourya, Pranavkumar Shivakumar, Lin Fei, Michael Wagner, Jorge A. Bezerra, Gianfranco D. Alpini
  PLOS ONE.2017; 12(8): e0182089.     CrossRef
• Metronidazole-induced encephalopathy in a patient with Crohn's disease
  Jihye Kim, Jaeyoung Chun, Jae Yong Park, Seung Wook Hong, Joo Young Lee, Jin Woo Kang, Seongjun Hwang, Sang-Bae Ko, Jong Pil Im, Joo Sung Kim
  Intestinal Research.2017; 15(1): 124.     CrossRef
• Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review
  Alexander L.A. Bloemendaal, Nicolas C. Buchs, Bruce D. George, Richard J. Guy
  Surgery.2016; 159(5): 1237.     CrossRef
• Antimicrobial peptides and wound healing: biological and therapeutic considerations
  Maria Luisa Mangoni, Alison M. McDermott, Michael Zasloff
  Experimental Dermatology.2016; 25(3): 167.     CrossRef
• The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease
  Lihua Sun, Wensheng Wang, Weidong Xiao, Hua Yang
  Inflammatory Bowel Diseases.2016; 22(8): 1986.     CrossRef
• A glance at … dietary emulsifiers, the human intestinal mucus and microbiome, and dietary fiber
  Michael J. Glade, Michael M. Meguid
  Nutrition.2016; 32(5): 609.     CrossRef
• Antimicrobial and antiviral effects of human defensins: pathogenetic value and prospective application to medicinal therapy
  Vladimir I Vaschenko, Vladimir N Vil’yaninov, Petr D Shabanov
  Reviews on Clinical Pharmacology and Drug Therapy.2016; 14(2): 3.     CrossRef
• Cross-Regulation of Innate and Adaptive Immunity: A New Perspective for the Pathogenesis of Inflammatory Bowel Disease
  Da Yeon Oh, Seong-Joon Koh
  Gut and Liver.2015;[Epub]     CrossRef
• Epigenetic Alterations in Inflammatory Bowel Disease and Cancer
  Joo Mi Yi, Tae Oh Kim
  Intestinal Research.2015; 13(2): 112.     CrossRef

Citations

Citations to this article as recorded by  

• Nanomagnetic Liposome-Encapsulated Parthenolide and Indocyanine Green for Targeting and Chemo-Photothermal Antitumor Therapy
  Wenbin Gao, Lei Li, Xuwu Zhang, Liyao Luo, Yuchu He, Cong Cong, Dawei Gao
  Nanomedicine.2020; 15(9): 871.     CrossRef
• Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy
  Wenbin Gao, Shipan Wei, Zhuo Li, Lei Li, Xuwu Zhang, Chunhui Li, Dawei Gao
  Nanotechnology.2020; 31(35): 355104.     CrossRef
• Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
  Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
  Molecular Biology Reports.2020; 47(8): 5807.     CrossRef
• Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
  Malgorzata Sztiller-Sikorska, Malgorzata Czyz
  Pharmaceuticals.2020; 13(8): 194.     CrossRef
• Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
  Ali Hassanzadeh, Majid Farshdousti Hagh, Mohammad Reza Alivand, Ali Akbar Movassaghpour Akbari, Karim Shams Asenjan, Raedeh Saraei, Saeed Solali
  Journal of Cellular Physiology.2018; 233(10): 6470.     CrossRef
• Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species
  Gabriela Flores‐Lopez, Dafne Moreno‐Lorenzana, Manuel Ayala‐Sanchez, Socrates Aviles‐Vazquez, Hector Torres‐Martinez, Peter A. Crooks, Monica L. Guzman, Hector Mayani, Antonieta Chávez‐González
  Journal of Cellular and Molecular Medicine.2018; 22(10): 4899.     CrossRef
• Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation
  Se-Lim Kim, Seong Hun Kim, Young Ran Park, Yu-Chuan Liu, Eun-Mi Kim, Hwan-Jeong Jeong, Yo Na Kim, Seung Young Seo, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang-Wook Kim
  Molecular Cancer Research.2017; 15(2): 141.     CrossRef
• Protective effects of Alpha-lipoic acid on MeHg-induced oxidative damage and intracellular Ca2+dyshomeostasis in primary cultured neurons
  Tianyao Yang, Zhaofa Xu, Wei Liu, Bin Xu, Yu Deng
  Free Radical Research.2016; 50(5): 542.     CrossRef
• Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats
  Gracianny Gomes Martins, Francislaine Aparecida dos Reis Lívero, Aline Maria Stolf, Caroline Machado Kopruszinski, Cibele Campos Cardoso, Olair Carlos Beltrame, José Ederaldo Queiroz-Telles, Regiane Lauriano Batista Strapasson, Maria Élida Alves Stefanell
  Chemico-Biological Interactions.2015; 228: 46.     CrossRef
• Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
  Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
  Intestinal Research.2015; 13(3): 233.     CrossRef
• Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation
  THANET SOPHONNITHIPRASERT, SIRINUN NILWARANGKOON, YUKIO NAKAMURA, RAMIDA WATANAPOKASIN
  International Journal of Oncology.2015; 47(6): 2188.     CrossRef

Citations

Citations to this article as recorded by  

• Intestinal tuberculosis with small bowel stricture and hemorrhage as the predominant manifestation: Three case reports
  Gang Huang, Kang-Kang Wu, Xiao-Na Li, Jing-Hua Kuai, Ai-Jun Zhang
  World Journal of Gastrointestinal Surgery.2024; 16(1): 248.     CrossRef
• Digestive Tract Tuberculosis Guideline
  Mohamed Tahiri, Khean-Lee Goh, Zaigham Abbas, David Epstein, Chen Min-Hu, Chris J.J. Mulder, Amarender Singh Puri, Michael Schultz, Anton LeMair, Jim Melberg
  Journal of Clinical Gastroenterology.2023; 57(7): 643.     CrossRef
• Visceral Fat Indices: Do They Help Differentiate Crohn’s Disease and Intestinal Tuberculosis in Children?
  Jayendra Seetharaman, Anshu Srivastava, Rajanikant R Yadav, Sumit K Singh, Prabhakar Mishra, Moinak Sen Sarma, Ujjal Poddar
  Journal of Crohn's and Colitis.2023; 17(12): 2026.     CrossRef
• Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review
  Arup Choudhury, Jasdeep Dhillon, Aravind Sekar, Pankaj Gupta, Harjeet Singh, Vishal Sharma
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis
  Vishal Sharma
  Expert Review of Gastroenterology & Hepatology.2020; 14(8): 647.     CrossRef
• Differentiating Crohn’s disease from intestinal tuberculosis
  Saurabh Kedia, Prasenjit Das, Kumble Seetharama Madhusudhan, Siddhartha Dattagupta, Raju Sharma, Peush Sahni, Govind Makharia, Vineet Ahuja
  World Journal of Gastroenterology.2019; 25(4): 418.     CrossRef
• The Adipokine Metrnl Ameliorates Chronic Colitis in Il-10–/– Mice by Attenuating Mesenteric Adipose Tissue Lesions During Spontaneous Colitis
  Lugen Zuo, Sitang Ge, Yuanyuan Ge, Jingjing Li, Bing Zhu, Zongbing Zhang, Congqiao Jiang, Jing Li, Suanhu Wang, Mulin Liu, Shiqing Li, Rong Wu, Jianguo Hu
  Journal of Crohn's and Colitis.2019; 13(7): 931.     CrossRef
• Indian guidelines on imaging of the small intestine in Crohn’s disease: A joint Indian Society of Gastroenterology and Indian Radiology and Imaging Association consensus statement
  Saurabh Kedia, Raju Sharma, Govind Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C Ghosha, Naveen Kalra, R Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Puri, Sunil Puri, Saroj
  Indian Journal of Radiology and Imaging.2019; 29(02): 111.     CrossRef
• Serum proteome profiles to differentiate Crohn disease from intestinal tuberculosis and primary intestinal lymphoma
  Longgui Ning, Guodong Shan, Zeyu Sun, Xinhe Lou, Fenming Zhang, Sha Li, Haojie Du, Jinghua Yu, Hongtan Chen, Guoqiang Xu
  Medicine.2019; 98(50): e18304.     CrossRef
• Creeping fat in patients with ileo‐colonic Crohn's disease correlates with disease activity and severity of inflammation: A preliminary study using energy spectral computed tomography
  Qi Feng, Xi Tao Xu, Yi Zhou, Yun Qi Yan, Zhi Hua Ran, Jiong Zhu
  Journal of Digestive Diseases.2018; 19(8): 475.     CrossRef
• Making a Positive Diagnosis of Intestinal Tuberculosis with the Aid of New Biologic and Histologic Features: How Far Have We Reached?
  Vatsal Mehta, Devendra Desai, Philip Abraham, Camilla Rodrigues
  Inflammatory Intestinal Diseases.2018; 3(4): 155.     CrossRef
• Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
  Saurabh Kedia, Raju Sharma, Vishnubhatla Sreenivas, Kumble Seetharama Madhusudhan, Vishal Sharma, Sawan Bopanna, Venigalla Pratap Mouli, Rajan Dhingra, Dawesh Prakash Yadav, Govind Makharia, Vineet Ahuja
  Intestinal Research.2017; 15(2): 149.     CrossRef
• Development and validation of visceral fat quantification as a surrogate marker for differentiation of Crohn's disease and intestinal tuberculosis
  Dawesh Prakash Yadav, Kumble Seetharama Madhusudhan, Saurabh Kedia, Raju Sharma, Venigalla Pratap Mouli, Sawan Bopanna, Rajan Dhingra, Rajesh Pradhan, Sandeep Goyal, Vishnubhatla Sreenivas, Naval K Vikram, Govind Makharia, Vineet Ahuja
  Journal of Gastroenterology and Hepatology.2017; 32(2): 420.     CrossRef
• Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association
  Saurabh Kedia, Raju Sharma, Govind K. Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C. Ghoshal, Naveen Kalra, D. Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Singh Puri, Sunil
  Indian Journal of Gastroenterology.2017; 36(6): 487.     CrossRef
• Intestinal tuberculosis and Crohn's disease: challenging differential diagnosis
  Jia Yi Ma, Jin Lu Tong, Zhi Hua Ran
  Journal of Digestive Diseases.2016; 17(3): 155.     CrossRef
• Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea
  Ho-Su Lee, Jaewon Choe, Hyo Jeong Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim, Suk-Kyun Yang
  Intestinal Research.2016; 14(3): 258.     CrossRef

Citations

Citations to this article as recorded by  

• Risk Factors for Colorectal Polyps
  嫣琦 王
  Advances in Clinical Medicine.2023; 13(09): 14803.     CrossRef
• Research Progress of Factors Related to CRP in Middle-Aged and Elderly People
  瑞武 邢
  Advances in Clinical Medicine.2022; 12(11): 10466.     CrossRef
• Association of gallbladder diseases with risk of gastrointestinal polyps
  Wenbin Geng, Xiangrong Qin, Peng Yang, Junmei Wang, Jing Yu, Xiaoyong Wang
  BMC Gastroenterology.2022;[Epub]     CrossRef
• Gallbladder Polyps Are Associated with Proximal Colon Polyps
  Kuan-Chieh Lee, Wen-Juei Jeng, Chen-Ming Hsu, Chia-Jung Kuo, Ming-Yao Su, Cheng-Tang Chiu
  Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
• Gallbladder Adenoumatous Polyps prevelance in Cholcystectomy in Saudi Arabia-cross sectional study
  Alharbi Mohammad
  Journal of Surgery and Surgical Research.2019; 5(1): 047.     CrossRef
• Gallbladder stones and gallbladder polyps associated with increased risk of colorectal adenoma in men
  Yen‐Ling Liu, Jin‐Shang Wu, Yi‐Ching Yang, Feng‐Hwa Lu, Chih‐Ting Lee, Wan‐Ju Lin, Chih‐Jen Chang
  Journal of Gastroenterology and Hepatology.2018; 33(4): 800.     CrossRef
• Risk of Colorectal Neoplasia According to Fatty Liver Severity and Presence of Gall Bladder Polyps
  Taeyoung Lee, Kyung Eun Yun, Yoosoo Chang, Seungho Ryu, Dong Il Park, Kyuyong Choi, Yoon Suk Jung
  Digestive Diseases and Sciences.2016; 61(1): 317.     CrossRef
• Can gallbladder polyps predict colorectal adenoma or even neoplasia? A systematic review
  Konstantinos Stergios, Christos Damaskos, Maximos Frountzas, Nikolaos Nikiteas, Olutunde Lalude
  International Journal of Surgery.2016; 33: 23.     CrossRef
• The Risk of Colorectal Neoplasia in Patients with Gallbladder Diseases
  Sung Noh Hong, Tae Yoon Lee, Sung-Cheol Yun
  Journal of Korean Medical Science.2015; 30(9): 1288.     CrossRef
• Recent Updates on the Diagnosis and Management of Gallbladder Polyps
  Eaum Seok Lee
  Korean Journal of Pancreas and Biliary Tract.2014; 19(2): 64.     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy and safety of same‐day preparation with sodium picosulfate plus magnesium citrate on the day of colonoscopy for bowel preparation: Multicenter, single‐arm, open‐label study
  Hitomi Hori, Nobuaki Ikezawa, Shinwa Tanaka, Chise Ueda, Mizuho Fujisawa, Shinya Hoki, Hiroshi Tanabe, Ryosuke Ishida, Norihiro Okamoto, Hiroshi Takayama, Haruka Miyazaki, Hiroya Sakaguchi, Masato Kinoshita, Hirofumi Abe, Tetsuya Yoshizaki, Makoto Ooi, Ma
  Journal of Gastroenterology and Hepatology.2024;[Epub]     CrossRef
• Comparison Between Same-Day and Split-Dose Preparations with Sodium Picosulfate/Magnesium Citrate: A Randomized Noninferiority Study
  Chen-Ta Yang, Hsuan-Yuan Huang, Hsu-Heng Yen, Chia-Wei Yang, Yang-Yuan Chen, Siou-Ping Huang
  Digestive Diseases and Sciences.2022; 67(8): 3964.     CrossRef
• Efectividad y tolerabilidad de tres tipos de productos de preparación para colonoscopia
  Luis Fernando Roldán Molina, Lina María Roldán Delfino, Sandra Milena León Ramírez, Edilberto Elías Nuñez Cabarcas, Hilda María Pérez Useche, Antonio José Restrepo Peláez, María Adelaida Saffón Abad, Julio Eduardo Zuleta Muñoz, Juan Nicolás Zuluaga Aguila
  Revista colombiana de Gastroenterología.2021; 36(3): 334.     CrossRef
• A prospective randomized clinical study evaluating the efficacy and compliance of oral sulfate solution and 2-L ascorbic acid plus polyethylene glycol
  Ki Hwan Kwon, Ji Ae Lee, Yun Jeong Lim, Beom Jae Lee, Moon Kyung Joo, Yu Ra Sim, Wonjae Choi, Taehyun Kim, Ji Yoon Kim, Ei Rie Cho, Yoon Tae Jeen, Jong-Jae Park
  The Korean Journal of Internal Medicine.2020; 35(4): 873.     CrossRef
• A randomized controlled trial on comparison of colon cleansing for colonoscopy bowel preparation using one-day or two-day regimen methods
  Saleh Azadbakht, Morteza Azadbakht, Salehe Azadbakht, Alireza Esmaili, Parisa Rahmani
  International Journal of Surgery Open.2020; 27: 140.     CrossRef
• Split-dose vs same-day bowel preparation for afternoon colonoscopies: A meta-analysis of randomized controlled trials
  Nasim Parsa, Eric A Grisham, Courtney J Cockerell, Michelle L Matteson-Kome, Ramakrishna V Bysani, Sami Samiullah, Douglas L Nguyen, Veysel Tahan, Yezaz A Ghouri, Srinivas R Puli, Matthew L Bechtold
  World Journal of Meta-Analysis.2020; 8(6): 461.     CrossRef
• Split-dose vs same-day bowel preparation for afternoon colonoscopies: A meta-analysis of randomized controlled trials
  Nasim Parsa, Eric A Grisham, Courtney J Cockerell, Michelle L Matteson-Kome, Ramakrishna V Bysani, Sami Samiullah, Douglas L Nguyen, Veysel Tahan, Yezaz A Ghouri, Srinivas R Puli, Matthew L Bechtold
  World Journal of Meta-Analysis.2020; 8(6): 462.     CrossRef
• Same-Day Regimen as an Alternative to Split Preparation for Colonoscopy: A Systematic Review with Meta-Analysis
  Cristina Bucci, Fabiana Zingone, Pietro Schettino, Clelia Marmo, Riccardo Marmo
  Gastroenterology Research and Practice.2019; 2019: 1.     CrossRef
• The Efficacy of Split-Dose Bowel Preparations for Polyp Detection: A Systematic Review and Meta-Analysis
  Kathleen Zawaly, Colin Rumbolt, Ahmed M. Abou-Setta, Christine Neilson, Rasheda Rabbani, Ryan Zarychanski, Harminder Singh
  American Journal of Gastroenterology.2019; 114(6): 884.     CrossRef
• Comparison of Bowel Cleansing Efficacy, Safety, Bowel Movement Kinetics, and Patient Tolerability of Same-Day and Split-Dose Bowel Preparation Using 4 L of Polyethylene Glycol: A Prospective Randomized Study
  Myeongsook Seo, Tae-Geun Gweon, Cheal Wung Huh, Jeong Seon Ji, Hwang Choi
  Diseases of the Colon & Rectum.2019; 62(12): 1518.     CrossRef
• Same-day Versus Split-dose Bowel Preparation Before Colonoscopy
  Yuan-Lung Cheng, Kuang-Wei Huang, Wei-Chih Liao, Jiing-Chyuan Luo, Keng-Hsin Lan, Chien-Wei Su, Yuan-Jen Wang, Ming-Chih Hou
  Journal of Clinical Gastroenterology.2018; 52(5): 392.     CrossRef
• Polyp detection rate may predict adenoma detection rate: a meta-analysis
  Yaron Niv
  European Journal of Gastroenterology & Hepatology.2018; 30(3): 247.     CrossRef
• Bowel Preparations Administered the Morning of Colonoscopy Provide Similar Efficacy to a Split Dose Regimen
  Danny J. Avalos, Fernando J. Castro, Marc J. Zuckerman, Tara Keihanian, Andrew C. Berry, Benjamin Nutter, Daniel A. Sussman
  Journal of Clinical Gastroenterology.2018; 52(10): 859.     CrossRef
• Sodium picosulphate or polyethylene glycol before elective colonoscopy in outpatients? A systematic review and meta-analysis
  Rodrigo Silva de Paula Rocha, Igor Braga Ribeiro, Diogo Turiani Hourneaux de Moura, Wanderley Marques Bernardo, Maurício Kazuyoshi Minata, Flávio Hiroshi Ananias Morita, Júlio Cesar Martins Aquino, Elisa Ryoka Baba, Nelson Tomio Miyajima, Eduardo Guimarãe
  World Journal of Gastrointestinal Endoscopy.2018; 10(12): 422.     CrossRef
• Low Volume Polyethylene Glycol (PEG) Plus Ascorbic Acid, a Valid Alternative to Standard PEG
  Su Hwan Kim, Ji Won Kim
  Gut and Liver.2016; 10(2): 160.     CrossRef
• Patient Descriptions of Rectal Effluents May Help to Predict the Quality of Bowel Preparation With Photographic Examples
  Hoonsub So, Sun-Jin Boo, Hyungil Seo, Ho-Su Lee, Hyojeong Lee, Sang Hyoung Park, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Jin-Ho Kim, Seungbong Han, Dong-Hoon Yang
  Intestinal Research.2015; 13(2): 153.     CrossRef
• Randomized controlled trial of low-volume bowel preparation agents for colonic bowel preparation: 2-L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate
  Seong Ran Jeon, Hyun Gun Kim, Ji Seong Lee, Jin-Oh Kim, Tae Hee Lee, Jun-Hyung Cho, Yong Hun Kim, Joo Young Cho, Joon Seong Lee
  International Journal of Colorectal Disease.2015; 30(2): 251.     CrossRef
• Colon Transit Time May Predict Inadequate Bowel Preparation in Patients With Chronic Constipation
  Hong Jun Park, Myeong Hun Chae, Hyun-Soo Kim, Jae Woo Kim, Moon Young Kim, Soon Koo Baik, Sang Ok Kwon, Hee Man Kim, Kyong Joo Lee
  Intestinal Research.2015; 13(4): 339.     CrossRef
• Bowel Preparation, the First Step for a Good Quality Colonoscopy
  Ho-Su Lee, Jeong-Sik Byeon
  Intestinal Research.2014; 12(1): 1.     CrossRef

Citations

Citations to this article as recorded by  

• Risk factors for peritonitis in patients on continuous ambulatory peritoneal dialysis who undergo colonoscopy: a retrospective multicentre study
  Tae-Geun Gweon, Sung Hoon Jung, Sang Woo Kim, Kang-Moon Lee, Dae Young Cheung, Bo-In Lee, Hwang Choi
  BMC Gastroenterology.2019;[Epub]     CrossRef
• A prospective randomized comparative study of cold forceps polypectomy by using narrow-band imaging endoscopy versus cold snare polypectomy in patients with diminutive colorectal polyps
  Soo-kyung Park, Bong Min Ko, Jae Pil Han, Su Jin Hong, Moon Sung Lee
  Gastrointestinal Endoscopy.2016; 83(3): 527.     CrossRef
• Is Retroflexion Helpful in Detecting Adenomas in the Right Colon?: A Single Center Interim Analysis
  Hyun Seok Lee, Seong Woo Jeon
  Intestinal Research.2015; 13(4): 326.     CrossRef
• Detection of Polyps Including Adenomas in the Ascending Colon by Cap-assisted Chromocolonoscopy with Indigo Carmine
  Hyun Seok Lee
  Intestinal Research.2014; 12(1): 3.     CrossRef

Crohn's disease (CD) may involve any part of the gastrointestinal tract, from the mouth to the anus. Approximately >90% of cases occur in the small bowel and colon. Upper gastrointestinal involvement, especially duodenal manifestation, is relatively rare. Therefore, adequate medical treatment for duodenal CD has not yet been established. We report a case of CD with duodenal involvement. A 46-year-old man with Crohn's ileocolitis presented to our hospital with right upper quadrant pain. An endoscopy showed a deep excavated ulcer with deformity at the duodenal bulb, and he was initially treated with azathioprine (1 mg/kg), Pentasa (3.0 g/day), and a proton pump inhibitor for 1 year. However, the deep ulcer did not heal. Therefore, infliximab infusion therapy was initiated, and the duodenal lesion completely resolved on follow-up esophagogastroduodenoscopy. We report a case of duodenal CD that completely resolved following infliximab infusion, with a review of the literature.

Citations

Citations to this article as recorded by  

• Duodenal Crohn’s disease: Case report and systematic review
  Muniratu Amadu, Jonathan Soldera
  World Journal of Methodology.2024;[Epub]     CrossRef
• An Obscure Presence of Gastroduodenal Involvement in a Newly Diagnosed Ileocolonic Crohn’s Disease Patient
  Clive Jude Miranda, Murad Hayatt Ali, Muddasir Ayaz, Yousef Soofi, Thomas Christopher Mahl, Hirotada Akiho
  Case Reports in Gastrointestinal Medicine.2022; 2022: 1.     CrossRef
• Challenges in Crohn's disease: Crohn's disease involving the duodenum
  Takayuki Yamamoto, Antonino Spinelli, Paulo Gustavo Kotze
  Seminars in Colon and Rectal Surgery.2020; 31(2): 100745.     CrossRef
• Isolated Severe Stricturing Duodenal Crohn Disease in a Pediatric Patient
  Keren L. Appel, Linda Wang, Dong Xi, Vrinda Bhardwaj
  JPGN Reports.2020; 1(2): e003.     CrossRef
• Crohn’s disease of esophagus, stomach and duodenum
  Andréa Maia Pimentel, Raquel Rocha, Genoile Oliveira Santana
  World Journal of Gastrointestinal Pharmacology and Therapeutics.2019; 10(2): 35.     CrossRef
• Duodenal Crohn’s Disease
  Amy L Lightner
  Inflammatory Bowel Diseases.2018; 24(3): 546.     CrossRef
• The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease
  S. R. Brown, N. S. Fearnhead, O. D. Faiz, J. F. Abercrombie, A. G. Acheson, R. G. Arnott, S. K. Clark, S. Clifford, R. J. Davies, M. M. Davies, W. J. P. Douie, M. G. Dunlop, J. C. Epstein, M. D. Evans, B. D. George, R. J. Guy, R. Hargest, A. B. Hawthorne,
  Colorectal Disease.2018; 20(S8): 3.     CrossRef
• The endoscopic findings of the upper gastrointestinal tract in patients with Crohn’s disease
  Yoshiki Nomura, Kentaro Moriichi, Mikihiro Fujiya, Toshikatsu Okumura
  Clinical Journal of Gastroenterology.2017; 10(4): 289.     CrossRef

Solitary rectal ulcer syndrome (SRUS) is an uncommon benign disease that is misdiagnosed as malignancy or inflammatory bowel disease because of similarities in clinical and endoscopic manifestations. Furthermore, SRUS with ulcerative colitis (UC) is extremely rare. To date, two cases have been reported in the medical literature. We report an additional case of SRUS with UC that was misdiagnosed as rectal cancer. A 61-year-old man was admitted to our hospital with rectal bleeding. Colonoscopy showed a well-demarcated, shallow, ulcerative lesion with polypoidal growth involving the entire circumference of the rectal lumen. Findings from imaging studies, including abdominal computed tomography (CT) and positron emission tomography (PET)/CT resembled those of rectal cancer. Surgical resection was performed because clinical symptoms persisted despite medical treatment and because occult rectal cancer could not be ruled out. Histopathological examination of the resected specimen revealed fibromuscular obliteration of the lamina propria and crypt abscesses, characteristics compatible with SRUS and UC.

Citations

Citations to this article as recorded by  

• Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review
  Matthew D Coates, Kofi Clarke, Emmanuelle Williams, Nimalan Jeganathan, Sanjay Yadav, David Giampetro, Vitaly Gordin, Sadie Smith, Kent Vrana, Anne Bobb, Thu Thi Gazzio, Heather Tressler, Shannon Dalessio
  Crohn's & Colitis 360.2023;[Epub]     CrossRef
• Management of elderly ulcerative colitis in Japan
  Masaaki Higashiyama, Akira Sugita, Kazutaka Koganei, Kenji Wanatabe, Yoko Yokoyama, Motoi Uchino, Masakazu Nagahori, Makoto Naganuma, Shigeki Bamba, Shingo Kato, Ken Takeuchi, Teppei Omori, Tomohisa Takagi, Satohiro Matsumoto, Mitsuo Nagasaka, Shintaro Sa
  Journal of Gastroenterology.2019; 54(7): 571.     CrossRef
• Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway
  Xiaohong Wang, Dan Li, Yong Zhang, Shuang Wu, Fang Tang
  Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
• A Case of Solitary Rectal Ulcer Syndrome in a 16-year-old Girl Presented with Iron Deficiency Anemia
  Sun Hee Jung, Young Bae Kim, Hyun Jin Kim, Jin Won Hwang, Sang Heon Lee, Su Jin Jung, Ji Kyoung Park
  Clinical Pediatric Hematology-Oncology.2016; 23(1): 53.     CrossRef
• Solitary Rectal Ulcer Syndrome in an Elderly Adult
  Hakan Demirci, Kadir Ozturk, Murat Kantarcioglu, Ahmet Uygun, Sait Bagci
  Journal of the American Geriatrics Society.2015; 63(6): 1270.     CrossRef

Nearly 80% of patients with Crohn's disease (CD) require surgical treatment for complications or failure of medical management. We managed a 31-year-old man with CD who presented with a post-operative fistula. The patient had undergone surgery due to multiple strictures and a fistula. However, a new fistula developed that connected to the intraperitoneal abscess. Intravenous antibiotics were started and multiple percutaneous drainage tubes were inserted to treat the abdominal abscess. However, the amount of drainage was consistently high, even one month after the operation. To treat the postoperative fistula, 5 mg/kg of infliximab was started, and the amount of drainage decreased dramatically to less than 10 cc a day. Some studies have reported that infliximab decreases the recurrence of CD after surgery. The effect of infliximab on post-operative fistulas in patients with CD has not been sufficiently studied. Our results indicated that the use of infliximab to treat post-operative fistula should be explored further in future clinical studies.

Citations

Citations to this article as recorded by  

• Treatment of abdominal fistulas in Crohn�s disease and monitoring with abdominal ultrasonography
  Nadia Moreno Sánchez, José María Paredes, Tomas Ripollés, Javier Sanz de la Vega, Patricia Latorre, María Jesús Martínez, José Richart, José Vizuete, Eduardo Moreno-Osset
  Revista Española de Enfermedades Digestivas.2020;[Epub]     CrossRef
• Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
  Min Chul Kim, Yoon Suk Jung, Young Seok Song, Jung In Lee, Jung Ho Park, Chong Il Sohn, Kyu Yong Choi, Dong Il Park
  Gut and Liver.2016;[Epub]     CrossRef
• Efficacy and safety of CT‐P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
  Yoon Suk Jung, Dong Il Park, Young Ho Kim, Ji Hyun Lee, Pyoung Ju Seo, Jae Hee Cheon, Hyoun Woo Kang, Ji Won Kim
  Journal of Gastroenterology and Hepatology.2015; 30(12): 1705.     CrossRef
• The clinical characteristics of patients with free perforation in Korean Crohn’s disease: results from the CONNECT study
  Young Seok Doh, You Sun Kim, Song I Bae, Jong Pil Im, Jae Hee Cheon, Byong Duk Ye, Ji Won Kim, Young Sook Park, Ji Hyun Lee, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Won Ho Kim
  BMC Gastroenterology.2015;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Colostrum supplementation enhance mental health status and alleviate pain in patients with acetabular fracture: A randomized, controlled, clinical trial
  Faezeh Gouhari, Reza Zandi, Shahin Talebi, Amir Mehrvar, Zahra Vahdat Shariatpanahi
  Journal of Functional Foods.2024; 119: 106325.     CrossRef
• The Influence of Feeding with Colostrum and Colostrum Replacer on Major Blood Biomarkers and Growth Performance in Dairy Calves
  Ramune Grigaleviciute, Rita Planciuniene, Ieva Prikockyte, Eivina Radzeviciute-Valciuke, Austeja Baleviciute, Augustinas Zelvys, Aukse Zinkeviciene, Vilma Zigmantaite, Audrius Kucinskas, Paulius Matusevicius, Povilas Kavaliauskas
  Veterinary Sciences.2023; 10(2): 128.     CrossRef

Citations

Citations to this article as recorded by  

• Histologic discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimens of colorectal polyp in actual clinical practice
  Moon Joo Hwang, Kyeong Ok Kim, A Lim Kim, Si Hyung Lee, Byung Ik Jang, Tae Nyeun Kim
  Intestinal Research.2018; 16(3): 475.     CrossRef